Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
---|
12/02/1998 | EP0881294A2 HOEFCC11, a HAS2 splicing variant |
12/02/1998 | EP0881292A2 Streptocococcus pneumoniae peptide release factor |
12/02/1998 | EP0881289A2 Novel 7TM receptor (H2CAA71) |
12/02/1998 | EP0881286A2 Histidine kinase |
12/02/1998 | EP0881285A1 D-Alanine transferase |
12/02/1998 | EP0880971A2 Macrophage stimulating protein for the treatment of pathologies of the nervous system |
12/02/1998 | EP0880701A1 Methods of assessing mhc class i expression and proteins capable of modulating class i expression |
12/02/1998 | EP0880596A1 Receptor specific chimeric viral surface polypeptides for viral and particle incorporation and internalization in target cells |
12/02/1998 | EP0880594A1 Retroviral vector and its use in gene therapy |
12/02/1998 | EP0880587A1 Gene therapy method using fgf-5 |
12/02/1998 | EP0880536A2 Process for preparing purified nucleic acid and the use thereof |
12/02/1998 | EP0880530A1 Phosphatidyl oligoglycerols |
12/02/1998 | EP0880360A1 Novel methods of vaccination and vaccines therefore comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope |
12/02/1998 | EP0787206A4 USE OF NEURITE LOCALIZED mRNAs FOR MEDICAL DIAGNOSIS AND THERAPEUTICS |
12/02/1998 | EP0542887B1 Psoralen conjugated methylphosphonate oligonucleotides as therapeutic agents for chronic myelogenous leukemia |
12/02/1998 | CN1200763A New adhesion from helicobactor pylori |
12/02/1998 | CA2230963A1 A human 7-tm receptor similar to murine frizzled-6 gene |
12/01/1998 | US5844107 Compacted nucleic acids and their delivery to cells |
12/01/1998 | US5844079 Vertebrate embryonic pattern-inducing proteins, and uses related thereto |
12/01/1998 | US5844077 Use of conantokins for producing analgesia or for neuroprotection |
12/01/1998 | US5843914 Neurturin and related growth factors |
12/01/1998 | US5843913 Nucleic acid respiratory syncytial virus vaccines |
12/01/1998 | US5843882 Antiviral proteins and peptides |
12/01/1998 | US5843738 Oligonucleotide modulation of cell adhesion |
12/01/1998 | US5843723 Alphavirus vector constructs |
12/01/1998 | US5843719 Cellubrevin homolog |
12/01/1998 | US5843714 DNA encoding a novel human proteolipid |
12/01/1998 | US5843688 Isolated tyrosinase derived peptides and uses thereof |
12/01/1998 | US5843687 Isolated, tyrosinase derived peptides and uses thereof |
12/01/1998 | US5843686 Methods of diagnosing metastatic cancer with MTS-1 protein |
12/01/1998 | US5843675 TNF receptor death domain ligand proteins and inhibitors of ligand binding |
12/01/1998 | US5843648 P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods |
12/01/1998 | US5843646 DNA molecules encoding murine son of sevenless (mSOS) gene and mSOS polypeptides |
12/01/1998 | US5843643 Site-specific transfection of eukaryotic cells using polypeptide-linked recombinant nucleic acid |
12/01/1998 | US5843474 Method of dialysis treatment, and dialysis apparatus related thereto |
12/01/1998 | US5843458 Recombinant human cytomegalovirus having a US2 deletion |
12/01/1998 | US5843438 Peripheralization of hematopoietic stem cells |
12/01/1998 | US5843432 Retroviral vectors for the treatment of tumors, and cell lines containing them |
12/01/1998 | US5843431 Controlling proliferation of cells before and after encapsulation in a bioartificial organ by gene transformation |
12/01/1998 | US5843430 Methods of treating disease using sertoli cells and allografts or xenografts |
12/01/1998 | US5843423 Methods of stimulating hematopoietic cells with flt3-ligand |
12/01/1998 | US5843089 Stent lining |
11/30/1998 | CA2233577A1 Histidine kinase |
11/30/1998 | CA2233572A1 Histidine kinase |
11/30/1998 | CA2233554A1 Novel compounds |
11/30/1998 | CA2233547A1 Histidine kinase |
11/30/1998 | CA2233539A1 Histidine kinase |
11/29/1998 | CA2233565A1 Novel compounds |
11/29/1998 | CA2233561A1 Novel compounds |
11/29/1998 | CA2231723A1 Novel has2 splicing variant hoefc11: a target in chronic renal failure, inflammatory diseases and myocardial schemia |
11/27/1998 | CA2232817A1 Novel compounds |
11/26/1998 | WO1998053087A1 Method for the production of non-group c adenoviral vectors |
11/26/1998 | WO1998053075A2 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
11/26/1998 | WO1998053071A1 Modulators of tissue regeneration |
11/26/1998 | WO1998053068A1 Smad7 and uses thereof |
11/26/1998 | WO1998053063A2 Mammalian cell transduction for use in gene therapy |
11/26/1998 | WO1998053062A1 A human edg-6 receptor homologue |
11/26/1998 | WO1998052963A1 Fadd-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same |
11/26/1998 | WO1998052958A1 Human uncoupling protein 3 |
11/26/1998 | WO1998052615A1 Controlling immune response to specific antigens |
11/26/1998 | WO1998052614A2 Composition and method for enhancing transport across biological membranes |
11/26/1998 | WO1998052603A2 An influenza enveloped dna vaccine |
11/26/1998 | WO1998052597A1 Apoptosis-inducing gelsolin sequences |
11/26/1998 | WO1998052591A1 Glial cell line-derived neurotrophic factor receptors |
11/26/1998 | WO1998052581A1 Vectors and methods for immunization or therapeutic protocols |
11/26/1998 | WO1998037209A3 Expression vector for the permanent expression of foreign dna |
11/26/1998 | WO1998035554A3 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
11/26/1998 | WO1998031800A3 Human proteins |
11/26/1998 | WO1998030582A3 Secreted proteins and polynucleotides encoding them |
11/26/1998 | CA2783134A1 Mycobacterium tuberculosis antigens for immunotherapy and diagnosis of tuberculosis |
11/26/1998 | CA2290783A1 Modulators of tissue regeneration |
11/26/1998 | CA2290778A1 Fadd-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same |
11/26/1998 | CA2290774A1 Mycobacterium tuberculosis antigens for immunotherapy and diagnosis of tuberculosis |
11/26/1998 | CA2290713A1 A human edg-6 receptor homologue |
11/26/1998 | CA2290426A1 Glial cell line-derived neurotrophic factor receptors |
11/26/1998 | CA2290040A1 Smad7 and uses thereof |
11/26/1998 | CA2289945A1 Human uncoupling protein 3 |
11/26/1998 | CA2289918A1 Mammalian cell transduction for use in gene therapy |
11/25/1998 | EP0879889A2 A novel member of the IL-1 family, IL-1 delta |
11/25/1998 | EP0879888A2 Patched-2 polypeptides and polynucleotides and methods for their production |
11/25/1998 | EP0879887A1 A human gene similar to a secreted murine protein SDF5 (ATG-1622) |
11/25/1998 | EP0879885A1 A novel human gene similar to a secreted murine protein sFRP-1 |
11/25/1998 | EP0879883A1 ATG-1120 (AIF-1-DELTA), a splice variant of AIF-1/RC-9 |
11/25/1998 | EP0879882A1 ATG-1100 (AIF-1-Gamma), a splice variant of AIF-1/RC-9 |
11/25/1998 | EP0879881A1 A human gene similar to a secreted protein frizb (ATG-1639) |
11/25/1998 | EP0879880A1 ATG-1117 (AIF-3), a homolog of allograft inflammatory factor-1/RC-9 |
11/25/1998 | EP0879879A2 Polypeptide deformylase 1 (Def1) |
11/25/1998 | EP0879294A1 Transduced human hematopoietic stem cells |
11/25/1998 | EP0879289A1 Human dnase resistant to actin inhibition |
11/25/1998 | EP0879288A1 Variants of thymidine kinase, related nucleic acids sequences and their use in genic therapy |
11/25/1998 | EP0879284A1 Gene expression vectors which generate an antigen specific immune response and methods of using the same |
11/25/1998 | EP0879281A2 Methods and compositions for transforming dendritic cells and activating t cells |
11/25/1998 | EP0879279A1 Diabetes therapy |
11/25/1998 | EP0879241A1 Inhibition of tumor growth by antisense oligonucleotides for il-8 and il-8 receptor |
11/25/1998 | EP0879062A2 Nucleic acid delivery vehicle |
11/25/1998 | CN1200147A Compounds and methods for immunotherapy and diagnosis of tuberculosis |
11/24/1998 | US5840878 Tablets of glass and/or zirconium/silicate beads in dissolvable binder (e.g.trehalose); lysis of cell walls and separation of nucleic acids from other cellular components |
11/24/1998 | US5840845 Senescent cell derived inhibitors of DNA synthesis |
11/24/1998 | US5840839 Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein |
11/24/1998 | US5840710 Cationic amphiphiles containing ester or ether-linked lipophilic groups for intracellular delivery of therapeutic molecules |